NEUTROPHIL-LYMPHOCYTE RATIO: A PREDICTOR OF COMPLICATIONS IN TYPE 2 DIABETES MELLITUS PATIENTS
DOI:
https://doi.org/10.59058/jaimc.v20i3.65Keywords:
NLR, T2DM, Microvascular Complications, Macrovascular complications, Inflammation.Abstract
Background: Chronic inflammation plays a potential role in development of diabetes related complications in type 2 diabetes mellitus (T2DM). Neutrophil-lymphocyte ratio (NLR) is one of the potential markers of systemic inflammation. The objective of this study was to examine an association between NLR and T2DM associated complications.
Methods: A cross sectional study was conducted at Sheikh Zayed Medical College & affiliated hospital in Rahim Yar Khan from June - September 2022. About 360 patients were divided in to three groups. Group A were comprised of T2DM patients without diabetic complications while group B and C were T2DM patients with micro- and macro-vascular complications respectively. Micro- and macrovascular complications were assessed by history, physical examination and medical records. Association of diabetes related compilations with NLR value was done using regression analysis with SPSS version 25.
Results: The baseline demographic characteristics of three study groups did not show statistically significant difference. However TLC count is significantly elevated in group B (with microvascular complications) and group C T2DM with macrovascular complications (P<0.001) respectively compared to control group A. Similarly NLR ratio was significantly higher (4.8±2.0 & 5.0±1.8) in group B and group C respectively, compared to group A (2.2±0.8 with P<0.001). Regression analysis showed that NLR was positively correlated with diabetes related micro and macrovascular complications (OR: 4.62, 95% CI: 2.51-7.26, p<0.001) along with HbA1c (OR: 1.732, 95% CI: 1.82-2.22, P=0.002).
Conclusion: High NLR ratio is associated with diabetes related micro and macro vascular complications. It should be routinely measured in T2DM patients for prevention of diabetes related complications.
References
Misra A, Gopalan H, Jayawardena R, Hills AP, Soares M, Reza‐Albarrán AA, Ramaiya KL. Diabetes in deve- loping countries. J Diabetes. 2019; 11(7):522-39.
Swarnkar PK, Kumar A, Garg AK, Agarwal AK, Singhal E. Prevalence of Coronary Risk Factors in Patients with Type 2 Diabetes Mellitus. J Indian Acad Clin Med. 2022; 23(1-2):7.
Luc K, Schramm-Luc A, Guzik TJ, Mikolajczyk TP. Oxidative stress and inflammatory markers in predia- betes and diabetes. J Physiol. Pharmacol; 70(6):111-3.
Jin HY, Park TS. Role of inflammatory biomarkers in diabetic peripheral neuropathy. J Diabetes Investig. 2018; 9(5):1016.
Luc K, Schramm-Luc A, Guzik TJ, Mikolajczyk TP. Oxidative stress and inflammatory markers in predia- betes and diabetes. J. Physiol. Pharmacol. 2019;70(6): 111-3.
Muzurović E, Stanković Z, Kovačević Z, Škrijelj BŠ, Mikhailidis DP. Inflammatory markers associated with diabetes mellitus–old and new players. Curr Pharm Des. 2021; 27(27):3020-35.
Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021; 122(7):474-88.
Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases. Int J Mol Sci. 2022; 23(7):3636.
Balta S, Celik T, Mikhailidis DP, Ozturk C, Demirkol S, Aparci M, et al. The relationship between athero- sclerosis and the neutrophil lymphocyte ratio. Clin Appl Thromb Hemost. 2016;22(5):405-411. Doi: 10. 1177/1076029615569568.
Balta S, Kurtoglu E, Kucuk U, Demirkol S, Ozturk C. Neutrophil lymphocyte ratio as an important assess- ment tool. Expert Rev Cardiovasc Ther. 2014; 12(5): 537-538.
Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, et al. Which white blood cell subtypes pre- dict increased cardiovascular risk? J Am Coll Cardiol. 2005;45(10):1638-1643.
Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther. 2013; 11(1):55-59. doi:10.1586/erc.12.159.
Bao X, Zhou G, Xu W, Liu X, Ye Z, Jiang F. Neutrophil- to-lymphocyte ratio and platelet-to-lymphocyte ratio: novel markers for the diagnosis and prognosis in patients with restenosis following CAS. Biomark Med. 2020; 14(4):271-82.
Hussain M, Babar MZ, Akhtar L, Hussain MS. Neutro- phil lymphocyte ratio (NLR): A well assessment tool of glycemic control in type 2 diabetic patients. Pak J Med Sci. 2017; 33(6):1366.
Shiny A, Bibin YS, Shanthirani CS, Regin BS, Anjana RM, Balasubramanyam M, et al.Association of neutro- phil lymphocyte ratio with glucose intolerance: an indicator of systemic inflammation in patients with type 2 diabetes. Diabetes Technol Ther. 2014; 16(8): 524-530.
Lou M, Luo P, Tang R, Peng Y, Yu S, Huang W, et al. Relationship between neutrophil lymphocyte ratio and insulin resistance in newly diagnosed type 2 dia- betes mellitus patients. BMC Endocr Disord. 2015; 15(1):9.
Ocak Ö, Şahin EM. Value of neutrophil/lymphocyte ratio in the diagnosis of diabetic neuropathy. Int J Dia- betes Dev Ctries. 2022:1-6.
Jaaban M, Zetoune AB, Hesenow S, Hessenow R. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as novel risk markers for diabetic nephropathy in patients with type 2 diabetes. Heliyon. 2021; 7(7): e07564.
Liu J, Liu X, Li Y, Quan J, Wei S, An S, Yang R, Liu J. The association of neutrophil to lymphocyte ratio, mean platelet volume, and platelet distribution width with diabetic retinopathy and nephropathy: a meta- analysis. Biosci Rep. 2018; 38(3).
Bhattacharyya S, Jain N, Verma H, Sharma K. ACross- sectional Study to assess Neutrophil Lymphocyte Ratio as a predictor of microvascular complications in Type 2 Diabetes Mellitus patients. J Clin Diagn Res. 2021; 15(8).
Mohammad WH, Ahmad AB, Al-Maghraby MH, Abdelrhman MZ, Ezzate S. Is neutrophil-lymphocyte ratio a novel biomarker for macrovascular and micro- vascular complications of type 2 diabetes?. Egypt J Intern Medi. 2019; 31(1):1-7.
Chen Y, Chai Q, Wang Q, Zhang Z, Shan Y, Lu D, Liu M, Wu W. Neutrophil-to-lymphocyte ratio is associated with coronary microvascular dysfunction in type 2 diabetes mellitus patients. Diabetes Res Clin Pract. 2021; 178:108983.
Serban D, Papanas N, Dascalu AM, Kempler P, Raz I, RizviAA, Rizzo M, Tudor C, Silviu Tudosie M, Tana- sescu D, Pantea Stoian A. Significance of neutrophil to lymphocyte ratio (nlr) and platelet lymphocyte ratio (plr) in diabetic foot ulcer and potential new therapeutic targets. Int J Lower Extrem Wounds. 2021: 1534734 6211057742.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 JAIMC
This work is licensed under a Creative Commons Attribution 4.0 International License.
The articles published in this journal come under creative commons licence Attribution 4.0 International (CC BY 4.0) which allows to copy and redistribute the material in any medium or format Adapt — remix, transform, and build upon the material for any purpose, even commercially under following terms.
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
The editorial board of the Journal strives hard for the authenticity and accuracy of the material published in the Journal. However, findings and statements are views of the authors and do not necessarily represent views of the Editorial Board. Many software like (Google Maps, Google Earth, Biorender (free version)) restricts the free distribution of materials prepared using these softwares. Therefore, authors are strongly advised to check the license/copyright information of the software used to prepare maps/images. In case of publication of copyright material, the correction will be published in one of the subsequent issues of the Journal, and the authors will bear the printing cost.
